rs200978001
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PVS1_ModerateBS2
The NM_170682.4(P2RX2):c.381+2T>C variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000293 in 1,609,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_170682.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
P2RX2 | NM_170682.4 | c.381+2T>C | splice_donor_variant, intron_variant | ENST00000643471.2 | NP_733782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
P2RX2 | ENST00000643471.2 | c.381+2T>C | splice_donor_variant, intron_variant | NM_170682.4 | ENSP00000494644.1 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152034Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000118 AC: 28AN: 238126Hom.: 0 AF XY: 0.000107 AC XY: 14AN XY: 131182
GnomAD4 exome AF: 0.000300 AC: 437AN: 1457584Hom.: 0 Cov.: 33 AF XY: 0.000275 AC XY: 199AN XY: 724876
GnomAD4 genome AF: 0.000223 AC: 34AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74396
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 01, 2022 | Canonical splice site variant in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 27, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 04, 2016 | The c.381+2T>C variant in P2RX2 has not been previously reported in individuals with hearing loss. It has been identified in 32/119906 European chromosomes by t he Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs200978001). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and is predi cted to cause altered splicing leading to an abnormal or absent protein. However , to date only 3 missense variants in P2RX2 have been associated with hearing lo ss (Yan 2013, Faletra 2014, Moteki 2015), and it is not clear if loss-of-functio n variant in P2RX2 can result in hearing loss. In summary, the clinical signific ance of the c.381+2T>C variant is uncertain due to lack of data supporting loss- of-function of P2RX2 as a disease mechanism. - |
Autosomal dominant nonsyndromic hearing loss 41 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 22, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at